Introduction
Colorectal cancer (CRC) is the third most common type of cancer and the second leading cause of cancer-related death worldwide, with approximately 1.9 million new cases annually. In Croatia, the National Colorectal Cancer Screening Program (NCCSP) has been implemented since 2007 for individuals aged 50 to 74; however, participation remains low, at around 20% of the target population. Despite the program’s implementation, most CRC cases are still detected at an advanced stage, resulting in high mortality and low five-year survival rates.
Results & Findings
Participants in the NCCSP were significantly younger compared to hospitalized patients (p = 0.003), while hospitalized patients more frequently had anemia and received antithrombotic therapy (p < 0.01). No statistically significant differences were found in the frequency of pathological findings (p = 0.089), polyps (p = 0.064), malignant lesions (p = 0.851), or the need for medical interventions (p = 0.136) between the observed groups. Age above 65 years was identified as a significant predictor of carcinoma occurrence (p = 0.033).
Summary & Discussion
The most significant differences between the groups were observed in hematological parameters, especially hemoglobin values. Hospitalized patients showed significantly lower means hemoglobin values compared to subjects in the NCCSP group (p < 0.001) which is expected given that anemia as an alarming symptom is often the reason for hospitalization and diagnostic workup. This finding emphasizes the importance of preventive screening with fecal occult blood testing (FOBT), since subjects in the screening program generally do not have anemia, and yet meet the criteria for colonoscopy due to a positive FOBT. The presence of anemia was almost exclusively associated with hospitalized patients, with microcytic anemia being the most common (50.0%), consistent with the chronic gastrointestinal blood loss characteristic of colorectal malignant and premalignant lesions. In contrast, subjects in the NCCSP group were 96.3% free of anemia, indicating early detection of changes before the development of clinically significant symptoms. Pathological findings, which included polyps and malignant formations, were recorded in 39 subjects (40.6%), while 57 subjects (59.4%) had normal findings. In the group of hospitalized patients, pathological findings were present in 13 of them (31%), while 29 (69%) had normal findings. In the group of subjects who participated in the NCCSP, pathological findings were recorded in 26 subjects (48%), and 28 (52%) had no pathological changes.
Conclusion
This study confirms that preventive screening enables the detection of colorectal lesions in the early, asymptomatic stage, as reflected by better hematological parameters and lower prevalence of anemia among screened participants. These findings highlight the importance of further strengthening and expanding preventive programs for early detection of colorectal cancer.
References
1. Katičić M, Antoljak N, Kujundžić M, Stamenić V, Skoko Poljak D, Kramarić D, et al. Results of National Colorectal Cancer Screening Program in Croatia (2007-2011). World J Gastroenterol. August 2012.;18(32):4300–7.
2. Herrero García A, Denis Filippini SE, de la Fuente A, Choolani Bhojwani E, Sánchez González J, Bailón Cuadrado M, et al. Preoperative haemoglobin as a predictor of in-hospital morbidity and 5-year mortality in colorectal cancer. Rev Esp Anestesiol Reanim. May 2025.;72(5):501723.
3. Araghi M, Soerjomataram I, Bardot A, Ferlay J, Cabasag CJ, Morrison DS. Changes in colorectal cancer incidence in seven high-income countries: a population-based study. Lancet Gastroenterol Hepatol. 2019.;4(7):511–8.